Limited Capability for Testing Mycobacterium tuberculosis for Susceptibility to New Drugs

We surveyed availability of phenotypic drug susceptibility testing for drug-resistant Mycobacterium tuberculosis in Europe. Of 27 laboratories, 17 tested for linezolid, 11 for clofazimine, 9 for bedaquiline, and 6 for delamanid during 2019. Our findings indicate that testing capacity for newer and r...

Descripción completa

Detalles Bibliográficos
Autores principales: Farooq, Hamzah Z., Cirillo, Daniela M., Hillemann, Doris, Wyllie, David, van der Werf, Marieke J., Ködmön, Csaba, Nikolayevskyy, Vlad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920658/
https://www.ncbi.nlm.nih.gov/pubmed/33622487
http://dx.doi.org/10.3201/eid2703.204418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7920658/
https://www.ncbi.nlm.nih.gov/pubmed/33622487
http://dx.doi.org/10.3201/eid2703.204418

Ejemplares similares